Michael R. Zile

MUSC Academic Setting

Author of 5 ePosters

 eCatalog Module
Heart Failure -> Heart Failure Management: -> Clinical Trials D-AB29 - LVADs, Barostim and Pacing Issues in HF management (ID 3) Abstract Plus

D-AB29-05 - Symptomatic Responder Rates To Barostim Therapy (ID 813)

Authors
Heart Failure -> Heart Failure Management: -> Clinical Trials D-AB30 - Clinical Trials: Heart Failure and Implantable Devices (ID 37) Abstract Plus

D-AB30-02 - Response To Barostim Therapy By Atrial Fibrillation Status (ID 814)

Authors
Disclosure
  M.R. Zile: Honoraria/Speaking/Consulting Fee - CVRx Inc.. Research (Contracted Grants for PIs and Named Investigators only) - CVRx Inc..
Heart Failure -> Heart Failure Management: -> Clinical Trials D-AB30 - Clinical Trials: Heart Failure and Implantable Devices (ID 37) Abstract Plus

D-AB30-04 - Are Intermediate Endpoints Associated With Serious Adverse Cardiovascular Events: Preliminary Results From The BeAT-HF Trial (ID 816)

Authors
Disclosure
  M.R. Zile: Honoraria/Speaking/Consulting Fee - CVRx Inc.. Research (Contracted Grants for PIs and Named Investigators only) - CVRx Inc..
Heart Failure -> Heart Failure Management: -> Clinical Trials D-MP02 - Newer technologies in managing and predicting outcomes in HF and AF patients (ID 50) Moderated ePoster

D-MP02-01 - Cost-Impact Analysis Of Baroreflex Activation Therapy In Patients With Chronic Heart Failure In The United States (ID 1)

Authors
Disclosure
  M.R. Zile: Honoraria/Speaking/Consulting Fee - CVRx Inc.. Research (Contracted Grants for PIs and Named Investigators only) - CVRx Inc..
Clinical Electrophysiology -> Atrial Fibrillation & Atrial Flutter: -> Physiology D-MP09 - Atrial Fibrillation: From Pathophysiology to Epidemiology to Treatment Options (ID 36) Moderated ePoster

D-MP09-05 - Racial Differences In Atrial Fibrillation Biomarkers (ID 847)

Authors
Disclosure
 P. Badertscher: Nothing relevant to disclose.